Novavax Inc (NVAX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$8.17

Buy

$8.18

arrow-up$0.035 (+0.43%)

Prices updated at 01 Apr 2026, 16:45 EDT

Prices minimum 15 mins delay

Prices in USD

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

NASDAQ

1.58%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Ms. Margaret G. McGlynn

CEO

Mr. John C. Jacobs

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

749

Head office

21 Firstfield Road

Gaithersburg

United States

20878

+1 240 268-2000

ir@novavax.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Gregg H. Alton, J.D. Independent Director	0.07m
Ms. Margaret G. McGlynn Chairman of the Board	0.08m
Mr. Richard J. Rodgers Independent Director	0.09m
Mr. David M. Mott Independent Director	0.08m
Dr. Richard H. Douglas, PhD Independent Director	0.08m
Ms. Rachel K. King Independent Director	0.07m
Mr. John C. Jacobs Director, President and Chief Executive Officer	0.75m
Mr. Charles W. Newton Independent Director	-
Mr. James P. Kelly Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer	0.55m
Dr. John W. Shiver, PhD Independent Director	-
Mr. Mark J. Casey Executive Vice President, Chief Legal Officer and Corporate Secretary	0.56m
Ms. Elaine O'Hara Executive Vice President and Chief Strategy Officer	0.54m
Dr. Ruxandra Draghia-Akli Executive Vice President and Head of Research and Development	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	15,470,365
Shah Capital Management	14,558,780
BlackRock Inc	12,773,053
State Street Corp	7,196,719
Sanofi	6,880,481

Director dealings

Date chevron-l-regular chevron-r-regular	Action
11 Dec 2025	-
11 Dec 2025	-
11 Dec 2025	-
11 Nov 2025	-
11 Nov 2025	-
11 Nov 2025	-
29 Oct 2025	-
29 Oct 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-
20 Jun 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.